Mary Rinella, MD, is a Professor of Medicine at Northwestern University’s Feinberg School of Medicine. For more than 15 years, she has worked on both basic mechanisms of steatohepatitis and clinical aspects of NASH.  Her current interests are in clinical trial development, the association between NASH metabolic comorbidities, and the recurrence of NASH after liver transplantation.  Her work has earned her recognition as a global authority in these fields.

Prof. Rinella currently serves as Chair of the NASH American Association for the Study of Liver Diseases (AASLD) Task Force and is past Chair of the NAFLD/NASH Special Interest Group at the AASLD.  She is the Director of the Northwestern Fatty Liver Program. She received her medical degree from the University of Illinois, Chicago, fulfilled her residency at the University of Chicago Hospitals, and completed her fellowship at Northwestern University McGaw Medical Center.

‍